Gambaran Umum
Ang Aspira Women's Health Inc., na nakabase sa United States, ay pangunahing gumagana sa sektor ng pangangalagang pangkalusugan, partikular na nakatuon sa kalusugan ng kababaihan. Ang kumpanya ay dalubhasa sa pagbuo ng mga makabagong diagnostic test na naglalayong pahusayin ang maagang pagtuklas at pamamahala ng mga sakit na ginekologiko, na may matinding diin sa ovarian cancer. Gamit ang mga advanced na teknolohiya tulad ng AI at machine learning, gumawa ang Aspira ng mahahalagang tool gaya ng OVA1plus—isang FDA-cleared na pagsubok na idinisenyo upang pahusayin ang pre-surgical assessment ng mga ovarian tumor. Ang pangako ng Aspira sa pagpapalawak ng portfolio ng produkto nito at pagpapabuti ng katumpakan ng diagnostic ay patuloy na inilalagay ito bilang isang pioneer sa pagbabago ng tanawin ng mga diagnostic ng kalusugan ng kababaihan.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Aspira Women's Health Inc. per 2025 Jun 30 adalah 9.29 MM.
- Nilai operating income untuk Aspira Women's Health Inc. per 2025 Jun 30 adalah -12.22 MM.
- Nilai net income untuk Aspira Women's Health Inc. per 2025 Jun 30 adalah -9.45 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 9.29 | -12.22 | -9.45 |
2025-03-31 | 9.31 | -14.81 | -10.32 |
2024-12-31 | 9.18 | -16.28 | -13.09 |
2024-09-30 | 8.96 | -16.98 | -14.79 |
2024-06-30 | 8.92 | -17.35 | -15.95 |
2024-03-31 | 8.99 | -17.28 | -14.74 |
2023-12-31 | 9.15 | -18.85 | -16.69 |
2023-09-30 | 9.18 | -19.81 | -18.19 |
2023-06-30 | 9.03 | -24.27 | -21.27 |
2023-03-31 | 8.61 | -28.17 | -27.20 |
2022-12-31 | 8.18 | -31.14 | -29.89 |
2022-09-30 | 7.88 | -34.99 | -34.26 |
2022-06-30 | 7.48 | -36.10 | -36.18 |
2022-03-31 | 7.21 | -35.96 | -35.01 |
2021-12-31 | 6.81 | -32.59 | -31.66 |
2021-09-30 | 6.41 | -29.47 | -28.78 |
2021-06-30 | 5.98 | -24.06 | -23.36 |
2021-03-31 | 4.93 | -19.82 | -20.12 |
2020-12-31 | 4.65 | -17.73 | -17.91 |
2020-09-30 | 4.51 | -15.31 | -15.21 |
2020-06-30 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | -0.62 | -0.62 |
2024-12-31 | -0.93 | |
2024-09-30 | -1.18 | -1.18 |
2024-06-30 | -1.43 | -1.43 |
2024-03-31 | -1.46 | -1.46 |
2023-12-31 | -1.81 | |
2023-09-30 | -2.09 | -2.09 |
2023-06-30 | -2.59 | -2.59 |
2023-03-31 | -3.41 | -3.41 |
2022-12-31 | -3.85 | |
2022-09-30 | -4.53 | -4.60 |
2022-06-30 | -4.84 | -4.74 |
2022-03-31 | -4.69 | -4.62 |
2021-12-31 | -4.27 | -4.27 |
2021-09-30 | -3.95 | -3.91 |
2021-06-30 | -3.27 | -3.34 |
2021-03-31 | -2.91 | -2.95 |
2020-12-31 | -2.67 | -2.70 |
2020-09-30 | -2.30 | -2.36 |
2020-06-30 | -2.27 | -2.32 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Aspira Women's Health Inc. per 2025 Jun 30 adalah -8.78 MM.
- Nilai cash from investing activities untuk Aspira Women's Health Inc. per 2025 Jun 30 adalah -0.00 MM.
- Nilai kas dari aktivitas pendanaan untuk Aspira Women's Health Inc. per 2025 Jun 30 adalah 9.36 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -8.78 | -0.00 | 9.36 |
2025-03-31 | -10.78 | -0.02 | 10.44 |
2024-12-31 | -12.11 | -0.04 | 11.06 |
2024-09-30 | -14.54 | -0.05 | 11.37 |
2024-06-30 | -14.94 | -0.05 | 11.45 |
2024-03-31 | -14.62 | -0.04 | 10.54 |
2023-12-31 | -15.89 | -0.02 | 5.22 |
2023-09-30 | -19.52 | -0.09 | 4.16 |
2023-06-30 | -23.71 | -0.14 | 7.62 |
2023-03-31 | -26.60 | -0.16 | 7.44 |
2022-12-31 | -31.07 | -0.23 | 7.43 |
2022-09-30 | -31.64 | -0.19 | 7.51 |
2022-06-30 | -32.13 | -0.15 | 0.02 |
2022-03-31 | -32.31 | -0.23 | 0.27 |
2021-12-31 | -27.39 | -0.18 | 48.38 |
2021-09-30 | -24.50 | -0.38 | 51.16 |
2021-06-30 | -19.57 | -0.50 | 62.13 |
2021-03-31 | -16.49 | -0.51 | 68.23 |
2020-12-31 | -14.73 | -0.49 | 20.15 |
2020-09-30 | -12.85 | -0.28 | 17.33 |
2020-06-30 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/e untuk Aspira Women's Health Inc. pada 2025 Jun 30 adalah -0.28.
- p/libro untuk Aspira Women's Health Inc. pada 2025 Jun 30 adalah -48.15.
- p/tbv untuk Aspira Women's Health Inc. pada 2025 Jun 30 adalah -48.15.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | -0.28 | -48.15 | -48.15 |
2025-03-31 | -0.13 | -0.68 | -0.68 |
2024-12-31 | -4.76 | -4.76 | |
2024-09-30 | -0.83 | -3.57 | -3.57 |
2024-06-30 | -1.11 | -11.97 | -11.97 |
2024-03-31 | -17.08 | -17.08 | |
2023-12-31 | -2.69 | -63.21 | -63.21 |
2023-09-30 | -3.04 | -103.91 | -103.91 |
2023-06-30 | -1.15 | 33.34 | 33.34 |
2023-03-31 | -1.69 | 6.81 | |
2022-12-31 | 3.79 | 3.79 | |
2022-09-30 | 3.25 | 3.25 | |
2022-06-30 | 3.05 | 3.05 | |
2022-03-31 | -3.68 | 3.87 | 3.87 |
2021-12-31 | -6.90 | 5.15 | 5.15 |
2021-09-30 | -15.57 | 7.76 | 7.76 |
2021-06-30 | |||
2021-03-31 | -4.66 | 1.79 | 1.79 |
2020-12-31 | -4.91 | 9.04 | 9.04 |
2020-09-30 | -5.74 | 6.01 | 6.01 |
2020-06-30 | -5.73 | 11.62 | 11.62 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Aspira Women's Health Inc. pada 2025 Jun 30 adalah -7.31.
- EBIT (3 tahun) / EV untuk Aspira Women's Health Inc. pada 2025 Jun 30 adalah -10.47.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -7.31 | -10.47 |
2025-03-31 | -6.22 | -8.20 |
2024-12-31 | -1.28 | -1.69 |
2024-09-30 | -1.14 | -1.55 |
2024-06-30 | -0.99 | -1.65 |
2024-03-31 | -0.42 | -0.63 |
2023-12-31 | -0.40 | -0.66 |
2023-09-30 | -0.34 | -0.49 |
2023-06-30 | -1.03 | -1.20 |
2023-03-31 | -0.75 | -0.76 |
2022-12-31 | -1.25 | -1.01 |
2022-09-30 | -1.27 | -0.94 |
2022-06-30 | -0.82 | -0.57 |
2022-03-31 | -0.38 | -0.27 |
2021-12-31 | -0.18 | -0.13 |
2021-09-30 | -0.07 | -0.06 |
2021-06-30 | ||
2021-03-31 | -0.52 | -0.41 |
2020-12-31 | -0.24 | -0.20 |
2020-09-30 | -0.22 | -0.20 |
2020-06-30 | -0.20 | -0.18 |
Efektivitas Manajemen
- roa untuk Aspira Women's Health Inc. pada 2025 Jun 30 adalah -2.60.
- roic untuk Aspira Women's Health Inc. pada 2025 Jun 30 adalah -3.44.
- croic untuk Aspira Women's Health Inc. pada 2025 Jun 30 adalah -0.12.
- ocroic untuk Aspira Women's Health Inc. pada 2025 Jun 30 adalah -3.60.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -2.60 | -3.44 | -0.12 | -3.60 | |
2025-03-31 | -1.83 | -16.11 | -1.34 | -14.90 | |
2024-12-31 | -2.36 | ||||
2024-09-30 | -1.84 | ||||
2024-06-30 | -1.28 | -17.82 | -11.13 | -3.11 | -11.04 |
2024-03-31 | -1.05 | -2.48 | -37.36 | -31.71 | -40.08 |
2023-12-31 | -0.65 | -1.38 | -10.84 | -9.20 | -11.63 |
2023-09-30 | -0.75 | -1.28 | -10.10 | -9.08 | -13.90 |
2023-06-30 | -1.00 | -1.70 | -5.88 | -5.29 | -8.09 |
2023-03-31 | -0.88 | -1.25 | -5.16 | 0.00 | -5.97 |
2022-12-31 | -0.65 | -0.81 | -2.13 | -1.67 | -2.25 |
2022-09-30 | -0.75 | -0.94 | -2.12 | -1.66 | -2.24 |
2022-06-30 | -0.63 | -0.75 | -2.02 | -1.80 | -1.80 |
2022-03-31 | -0.51 | -0.61 | -1.35 | -1.25 | -1.25 |
2021-12-31 | -1.47 | -2.96 | -0.94 | 0.62 | -0.58 |
2021-09-30 | -1.10 | -1.61 | -0.68 | 0.62 | -0.39 |
2021-06-30 | -1.78 | -3.21 | -0.47 | 0.84 | -0.39 |
2021-03-31 | -1.94 | -3.79 | -0.35 | 0.90 | -0.29 |
2020-12-31 | -1.29 | -2.05 | -1.21 | 0.33 | -0.99 |
2020-09-30 | -0.92 | -1.29 | -0.89 | 0.25 | -0.75 |
2020-06-30 | -0.81 | -1.10 | -1.65 | -0.59 | -1.48 |
Gross Margins
- marjin kotor untuk Aspira Women's Health Inc. pada 2025 Jun 30 adalah 0.63.
- marjin bersih untuk Aspira Women's Health Inc. pada 2025 Jun 30 adalah -1.02.
- marjin operasi untuk Aspira Women's Health Inc. pada 2025 Jun 30 adalah -1.32.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.63 | -1.02 | -1.32 |
2025-03-31 | 0.60 | -1.43 | -1.77 |
2024-12-31 | 0.58 | -1.65 | -1.89 |
2024-09-30 | 0.58 | -1.79 | -1.94 |
2024-06-30 | 0.59 | -1.64 | -1.92 |
2024-03-31 | 0.58 | -1.82 | -2.06 |
2023-12-31 | 0.58 | -1.69 | -2.34 |
2023-09-30 | 0.57 | -2.00 | -2.81 |
2023-06-30 | 0.53 | -2.00 | -2.81 |
2023-03-31 | 0.53 | -2.78 | -3.40 |
2022-12-31 | 0.52 | -3.94 | -4.58 |
2022-09-30 | 0.49 | -3.94 | -4.58 |
2022-06-30 | 0.47 | -4.84 | -4.83 |
2022-03-31 | 0.45 | -4.86 | -4.99 |
2021-12-31 | 0.36 | -4.65 | -4.78 |
2021-09-30 | 0.33 | -4.49 | -4.64 |
2021-06-30 | 0.33 | -3.91 | -4.07 |
2021-03-31 | 0.29 | -4.08 | -4.07 |
2020-12-31 | 0.27 | -3.85 | -3.87 |
2020-09-30 | 0.34 | -3.37 | -3.39 |
2020-06-30 | 0.31 | -3.23 | -3.26 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 926617 |
Grupong Pang-industriya
SIC 2835 - In Vitro and In Vivo Diagnostic Substances |